AYTU BIOPHARMA, INC Quarterly Income Tax Expense (Benefit) in USD from Q1 2014 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Aytu Biopharma, Inc annual/quarterly Income Tax Expense (Benefit) history and growth rate from Q1 2014 to Q1 2024.
  • Aytu Biopharma, Inc Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $245K.
  • Aytu Biopharma, Inc annual Income Tax Expense (Benefit) for 2024 was $1.77M.
  • Aytu Biopharma, Inc annual Income Tax Expense (Benefit) for 2023 was $0.000.
  • Aytu Biopharma, Inc annual Income Tax Expense (Benefit) for 2022 was -$110K, a 142% decline from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $245K +$245K Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $828K +$828K Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-14
Q1 2023 $0 Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $0 +$3K Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-14
Q4 2021 -$3K -$3K Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-21
Q3 2021 -$107K -$107K Jul 1, 2021 Sep 30, 2021 10-Q/A 2023-02-21
Q4 2020 $0 Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-14
Q3 2020 $0 Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q4 2017 $6.6M Oct 1, 2017 Dec 31, 2017 10-Q 2018-05-14
Q2 2016 $0 $0 $0 Apr 1, 2016 Jun 30, 2016 10-K 2017-08-31
Q1 2016 $0 $0 $0 Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-11
Q4 2015 $0 $0 $0 Oct 1, 2015 Dec 31, 2015 10-Q 2016-02-11
Q3 2015 $0 $0 +$23.9K Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-06
Q2 2015 -$23.9K $0 Apr 1, 2015 Jun 30, 2015 10-K 2016-09-01
Q1 2015 $0 +$323K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-11
Q4 2014 $0 Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-11
Q3 2014 -$23.9K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q1 2014 -$323K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.